SPDEF
Basic information
Region (hg38): 6:34537802-34556333
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPDEF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 2 | 2 |
Variants in SPDEF
This is a list of pathogenic ClinVar variants found in the SPDEF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-34538363-G-T | not specified | Uncertain significance (Sep 30, 2021) | ||
6-34538376-G-A | Likely benign (Nov 01, 2022) | |||
6-34538393-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
6-34538417-G-A | not specified | Uncertain significance (Jan 11, 2023) | ||
6-34539300-A-T | not specified | Uncertain significance (Apr 06, 2023) | ||
6-34539523-T-C | not specified | Uncertain significance (Jul 07, 2024) | ||
6-34539533-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
6-34539538-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
6-34539544-C-T | not specified | Uncertain significance (Jun 19, 2024) | ||
6-34539545-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
6-34541037-C-A | not specified | Uncertain significance (Feb 23, 2023) | ||
6-34541058-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
6-34541065-C-T | not specified | Uncertain significance (Mar 06, 2025) | ||
6-34541082-G-A | not specified | Uncertain significance (Aug 05, 2024) | ||
6-34541110-G-C | not specified | Uncertain significance (Jun 30, 2023) | ||
6-34541114-C-G | Benign (May 21, 2018) | |||
6-34544029-T-C | not specified | Uncertain significance (Aug 29, 2022) | ||
6-34544128-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
6-34544175-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
6-34544196-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
6-34544209-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
6-34544223-G-A | not specified | Uncertain significance (Oct 12, 2024) | ||
6-34544224-G-A | not specified | Uncertain significance (May 28, 2024) | ||
6-34544227-C-A | not specified | Uncertain significance (Oct 14, 2021) | ||
6-34544242-T-C | not specified | Uncertain significance (Jun 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPDEF | protein_coding | protein_coding | ENST00000374037 | 5 | 18532 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.972 | 0.0282 | 125344 | 0 | 3 | 125347 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.797 | 186 | 219 | 0.849 | 0.0000146 | 2160 |
Missense in Polyphen | 56 | 83.137 | 0.67359 | 818 | ||
Synonymous | 0.0982 | 97 | 98.2 | 0.987 | 0.00000708 | 656 |
Loss of Function | 3.40 | 1 | 15.4 | 0.0648 | 6.61e-7 | 170 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000704 | 0.0000618 |
Ashkenazi Jewish | 0.000107 | 0.0000994 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000885 | 0.00000883 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May function as an androgen-independent transactivator of the prostate-specific antigen (PSA) promoter. Binds to 5'-GGAT- 3' DNA sequences. May play a role in the regulation of the prostate gland and/or prostate cancer development. Acts as a transcriptional activator for SERPINB5 promoter. {ECO:0000269|PubMed:10625666}.;
- Pathway
- AndrogenReceptor;Regulation of Androgen receptor activity
(Consensus)
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- 0.228
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.66
Haploinsufficiency Scores
- pHI
- 0.169
- hipred
- Y
- hipred_score
- 0.644
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.978
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spdef
- Phenotype
- respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; immune system phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;multicellular organism development;negative regulation of cell fate commitment;positive regulation of cell fate commitment;cell differentiation;positive regulation of apoptotic process;positive regulation of transcription by RNA polymerase II;lung goblet cell differentiation;intestinal epithelial cell development
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;sequence-specific DNA binding